SLC40A1 and cancer: More recently, Gao J. et al., performed an elegant demonstration of a new cancer therapy named gene-interfered-ferroptosis therapy (GIFT) by combining iron nanoparticles with cancer-specific gene interference, here targeting two iron metabolic genes (FPN and LCN2) both in vitro and in vivo [162].